Láimhseáil shealadach gnóthachan agus caillteanas neamhréadaithe arna dtomhas ar luach cóir trí ioncam cuimsitheach eile i bhfianaise phaindéim COVID-19
Temporary treatment of unrealised gains and losses measured at fair value through other comprehensive income in view of the COVID-19 pandemic
De mhaolú ar Airteagal 35, i rith na tréimhse ón 1 Eanáir 2014 go dtí an 31 Nollaig 2017, ní dhéanfaidh institiúidí, le linn dóibh ítimí Ghnáthchothromas Leibhéal 1 a ríomh, ach amháin an céatadán is infheidhme de chaillteanais neamhréadaithe a bhaineann le sócmhainní nó le dliteanais a rinneadh a thomhas de réir luacha chóir agus a thuairisciú ar an gclár comhardaithe a áireamh, cé is moite dóibh sin dá dtagraítear in Airteagal 33 agus gach caillteanas neamhréadaithe eile a rinneadh a thuairisciú mar chuid den chuntas brabúis agus caillteanais.
By way of derogation from Article 35, during the period from 1 January 2014 to 31 December 2017 institutions shall include in the calculation of their Common Equity Tier 1 items only the applicable percentage of unrealised losses related to assets or liabilities measured at fair value, and reported on the balance sheet, excluding those referred to in Article 33 and all other unrealised losses reported as part of the profit and loss account.
I gcás ina mbaineann institiúid méid caillteanas neamhréadaithe óna hítimí Ghnáthchothromas Leibhéal 1 i gcomhréir le mír 1 den Airteagal seo, déanfaidh sí na ceanglais uile a leagtar síos sa Rialachán seo agus i dTreoir 2013/36/AE a ríomhtar agus aon cheann de na hítimí seo a leanas á úsáid a athríomh:
Where an institution removes an amount of unrealised losses from its Common Equity Tier 1 items in accordance with paragraph 1 of this Article, it shall recalculate all requirements laid down in this Regulation and in Directive 2013/36/EU that are calculated using any of the following items: